Considering that a dramatic decrease in DR5 expression is noted 0.5 h after TRAIL injection, this could indicate that within the first 30 min, TRAIL binds to the majority of DR5 exposed on the surface of the tumor cells. This evidence concerns the gene TNFRSF10B and neoplasm.